Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
暂无分享,去创建一个
Wei Chen | Christopher I Amos | Mark Wener | Peter K Gregersen | Annette H M van der Helm-van Mil | P. Gregersen | C. Amos | W. Chen | F. Breedveld | L. Criswell | T. Huizinga | R. Toes | M. Wener | R. Lum | A. H. M. van der Helm-van Mil | R. de Vries | Raymond F Lum | Lindsey A Criswell | Tom W J Huizinga | Ferdinand C Breedveld | F. V. van Gaalen | Rene E M Toes | D. Jawaheer | Floris A van Gaalen | Damini Jawaheer | G. Schreuder | Naila Ahmad | Geziena M T Schreuder | Naila Ahmad | Rene R P de Vries | R. F. Lum
[1] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[2] B. Dijkmans,et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.
[3] A S Rigby,et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. , 2000, Arthritis and rheumatism.
[4] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[5] A. Sette,et al. Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule1 , 2003, The Journal of Immunology.
[6] M. V. van Leeuwen,et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[7] G Strandberg,et al. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project) , 2004, Annals of the rheumatic diseases.
[8] H. Schumacher,et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset , 2000, Arthritis research.
[9] H. Visser,et al. A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis , 2005, Annals of the rheumatic diseases.
[10] F. Breedveld,et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. , 2004, Arthritis and rheumatism.
[11] Xiangli Xiao,et al. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. , 2003, Arthritis and rheumatism.
[12] C. Allaart,et al. The Leiden Early Arthritis Clinic. , 2003, Clinical and experimental rheumatology.
[13] Madhukar Pai,et al. Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. , 2004, Arthritis and rheumatism.
[14] F. Breedveld,et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[15] M. Rewers,et al. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. , 2005, Arthritis and rheumatism.
[16] P. Gregersen,et al. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.
[17] J. Hazes,et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.
[18] Göran Hallmans,et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.
[19] P. Shekelle,et al. How to read radiographs according to the Sharp/van der Heijde method. , 1999 .
[20] G. Abecasis,et al. Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.